4(or 3)-(3,4-Dihydroxyphenyl)pyridines, their cardiotonic use an

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

546344, C07D21330, A61K 3144

Patent

active

043024629

ABSTRACT:
4(or 3)-(3,4-Dihydroxyphenyl)pyridine, a cardiotonic agent, is prepared by demethylating 4(or 3)-(3,4-dimethoxyphenyl)pyridine, preferably by heating with aqueous hydrogen bromide. 4(or3)-[3,4-di-(OR)-phenyl]pyridine, where R is hydrogen or methyl, or pharmaceutically-acceptable acid-addition salt thereof is disclosed as the active component in a cardiotonic composition for increasing cardiac contractility and in the method for increasing cardiac contractility in a patient requiring such treatment. The novel isomeric 2-[3,4-di-(OR)-phenyl]pyridine, where R is hydrogen or methyl, is shown for comparative purposes.

REFERENCES:
patent: 3575985 (1971-04-01), Ritchie et al.
Ginos et al., Journal of Medicinal Chemistry, vol. 18, No. 12, pp. 1194-1200, (1975).
Coates et al., Journal of the Chemical Society, London, 1943, pp. 406-413.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

4(or 3)-(3,4-Dihydroxyphenyl)pyridines, their cardiotonic use an does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 4(or 3)-(3,4-Dihydroxyphenyl)pyridines, their cardiotonic use an, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4(or 3)-(3,4-Dihydroxyphenyl)pyridines, their cardiotonic use an will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2174865

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.